Ye and colleagues observed an overexpression of CMG2 mRNA in prostate carcinoma cell lines in comparison with prostate epithelial cell lines, and that the knockdown of CMG2 enhanced the invasiveness of prostate tumor cells [32]. The gene discussed is ANTXR2; the disease is prostate neoplasm.